Search AI Products and News

Hangzhou-based medical AI company, MeiYin Intelligence Technology Co., Ltd., recently announced it has secured millions of yuan in seed funding. The funding will primarily be used for R&D and commercialization of its core product. The round was led by Zhuoyuan Asia, with participation from Xihu Government Direct Investment Fund. MeiYin Intelligence focuses on leveraging AI to predict disease risk and promote health management. Its core product, based on its self-developed DP-LLM large model, supports the processing of multimodal medical data to accurately quantify an individual's future disease risk, covering hundreds of diseases and more.

Glaucoma, the 'silent thief of sight,' threatens the vision of 26 million people in China. But now, a breakthrough has arrived. 'Xiao Qing,' a powerful AI tool, has been launched in collaboration with leading Chinese medical institutions to combat glaucoma and restore hope for patients. Recently, a 'Glaucoma Chronic Disease Management Center' was launched in Shanghai, a joint initiative of 12 top-tier hospitals including Fudan University Affiliated Eye, Ear, Nose, and Throat Hospital, Sun Yat-sen University Zhongshan Ophthalmic Center, and Beijing Tongren Hospital.

A significant advancement in Chinese medicine has been achieved with the recent clinical deployment of "Xiehe-Taichu," a rare disease AI model jointly developed by Peking Union Medical College Hospital and the Institute of Automation, Chinese Academy of Sciences. This marks a breakthrough in China's rare disease diagnostic technology and provides a new tool for improving clinical efficiency. The development of this AI model benefits from years of accumulated knowledge on rare diseases in China and the support of genetic testing data from the Chinese population. As the world's first rare disease model tailored to the characteristics of the Chinese population, it...

Recently, the Evo2 bio AI model, jointly developed by Arc Institute and Nvidia, was officially released. This foundational model is based on DNA data from over 100,000 species and aims to deeply decode various complex phenomena in biology. Evo2 can identify patterns in the genetic sequences of different organisms that researchers would typically take years to discover, significantly enhancing the ability to identify disease-related mutations, and can design entirely new genomes comparable to simple bacteria.

Recently, a user on Reddit shared a remarkable experience, claiming that the AI chatbot ChatGPT provided crucial assistance during a life-threatening situation by promptly diagnosing a rare kidney disease. The post quickly went viral, attracting significant attention and discussion among users. The user, with the username 'Ananymous717', reported feeling unusually unwell after what seemed like a simple workout. He recalled, 'About a week ago, I did a workout that I thought was low in intensity, but when I woke up...'

The research team from The Chinese University of Hong Kong (Shenzhen) and Shenzhen Big Data Institute has recently launched a medical large language model (LLM) named HuatuoGPT-o1. This model is specifically designed for complex reasoning in the medical field, aiming to enhance the reliability of medical diagnosis and decision-making. Unlike previous LLMs that focused on mathematical reasoning, HuatuoGPT-o1 specializes in the medical domain by simulating the rigorous thought processes of doctors in real-world practice, paving new avenues for the development of medical AI.

Recently, a study published in the journal "Cell Metabolism" revealed that researchers, using thermal imaging cameras and artificial intelligence technology, can detect various chronic diseases and assess an individual's physiological age by analyzing facial temperature. This innovative method offers new possibilities for early disease diagnosis and health monitoring.- The temperature of different areas on the face is associated with various chronic diseases, such as diabetes and hypertension.-

Researchers from the Department of Psychology at the University of Cambridge have recently made a significant breakthrough in the early diagnosis of Alzheimer's disease. They have developed an advanced artificial intelligence tool that can predict the progression of Alzheimer's disease with an accuracy of 80%. This innovative approach aims to reduce reliance on invasive and expensive dementia diagnostic tests while also hoping to significantly improve treatment outcomes in the early stages of th

With the continuous advancement of artificial intelligence technology, an innovative app called CatsMe! is revolutionizing the way we understand and care for pet cats. Developed by researchers from Carelogy and a Japanese university, this app uses AI to analyze subtle facial expressions of cats to detect signs of pain with an astonishing accuracy of over 95%.Cats naturally tend to hide their pain, an instinctive behavior they've evolved to avoid attracting predators. The Drake Veterinary Care Ce

Japanese startup Carelogy has partnered with a Japanese university to develop an app called 'CatsMe!' This program uses artificial intelligence (AI) technology to provide cat owners with a new way to understand and care for their beloved pets.

Recent research shows that ChatGPT-4 has an accuracy rate of only 17% in pediatric medical cases, which is lower than the 39% accuracy in general medical cases. Researchers point out that ChatGPT struggles to identify disease relationships and suggest specialized training and provision of accurate medical literature to improve the model's accuracy. The model correctly diagnosed only 17 out of 100 pediatric cases, with most errors concentrated in the same organ system.

Using AI to analyze OCT scanning data of the eyes can detect differences in the thickness of the cellular layers between patients with Parkinson's disease and non-patients. Researchers believe that eye scans can facilitate early detection of the disease and hope for routine implementation in the future. OCT scanning is non-invasive and has been widely used in ophthalmology to reveal cellular layer information.

A portable ultrasound machine developed by Mohammed bin Zayed University of Artificial Intelligence can help save millions of infant lives in developing countries. The combination of artificial intelligence technology and predictive diagnostics can quickly identify potentially treatable congenital heart defects in unborn babies. The findings of this research are expected to be promoted in health resource-limited developing countries, improving the early detection and treatment levels of infant heart disease.